Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar Disorders
NCT00330226 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2010-07-23
Summary
The purpose of this study is to investigate the efficacy and safety of long-term psychopharmacotherapy in schizophrenia or bipolar disorder in terms of psychopathology and side effects.
Conditions
Sponsors & Collaborators
-
Seoul National University Hospital
lead OTHER
Principal Investigators
-
Yong Sik Kim, MD, PhD · Seoul National University Hospital
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-01-31
- Completion
- 2012-12-31
Countries
- South Korea
Study Locations
More Related Trials
-
Study on Abnormal Dopamine Synthesis and Connectivity According to the Antipsychotic Treatment Response in Schizophrenia
NCT02248987 ·Status: COMPLETED
-
The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic Therapy
NCT01215383 ·Status: UNKNOWN
-
Music Therapy for People With Schizophrenia and Relates Psychosis.
NCT04777266 ·Status: COMPLETED ·Phase: NA
-
Effect of MMFS-202-302 on Cognitive Enhancement in Schizophrenia
NCT02237235 ·Status: COMPLETED ·Phase: PHASE2
-
Longitudinal Effect of Electroconvulsive Therapy on Schizophrenia and Bipolar Disorder: a MRI Study
NCT03651674 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy Study for Cognitive Deficits in Adult Subjects With Schizophrenia
NCT01095562 ·Status: COMPLETED ·Phase: PHASE2
-
Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia
NCT01545999 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Safety and Tolerability Study of Lu AF35700 After Repeated Dosing in Patients With Schizophrenia
NCT02202226 ·Status: COMPLETED ·Phase: PHASE1
-
Cerebellar Modulation of Cognition in Psychosis
NCT06107764 ·Status: RECRUITING ·Phase: NA
-
Changes in Auditory Verbal Hallucination During Atypical Antipsychotic Treatment of Patients With Schizophrenia
NCT00328952 ·Status: COMPLETED
-
Neurophysiological Studies in Schizophrenia and Psychiatric Disorders
NCT01384604 ·Status: COMPLETED
-
Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia Individuals
NCT03790085 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Identifying Predictors of Response to Antipsychotics Using a Treatment Algorithm
NCT01016145 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Paliperidone Palmitate in Schizophrenia
NCT01860781 ·Status: COMPLETED ·Phase: PHASE4
-
Biomarkers in First Episode Schizophrenia
NCT02033382 ·Status: COMPLETED
-
Schizophrenia Treatment With Photoneuromodulation
NCT05339347 ·Status: COMPLETED ·Phase: PHASE2
-
Adherence and Quality of Life in People With Schizophrenia and Schizoaffective Disorder
NCT01769014 ·Status: UNKNOWN
-
Side Effects of Psychiatric Medications - a Nested Case Control Cohort Historical Prospective Study
NCT05872555 ·Status: ACTIVE_NOT_RECRUITING
-
A Trial to Assess the Antipsychotic Efficacy of ITI-007
NCT02282761 ·Status: COMPLETED ·Phase: PHASE3
-
Indicated Prevention of Psychotic Disorders With Low-dose Lithium
NCT00202306 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating Pharmacogenomics-Based Pharmacotherapy in Real-World Settings for Schizophrenia
NCT06700967 ·Status: NOT_YET_RECRUITING
-
Neuropsychiatric Evaluation of Healthy Volunteers and Adults With Schizophrenia
NCT00001323 ·Status: COMPLETED
-
Treatment Study for Cognitive Deficits in Schizophrenia
NCT00505076 ·Status: COMPLETED ·Phase: PHASE2
-
Study of CAD-9303 in Subjects With Schizophrenia
NCT04306146 ·Status: COMPLETED ·Phase: PHASE1
-
Subjective Well Being of Schizophrenic Patients in Greece
NCT00857064 ·Status: COMPLETED